How should I evaluate and treat chronic constipation in an adult, including red‑flag assessment, workup, and stepwise management?

Chronic Constipation: Workup and Management

Red-Flag Assessment

Screen immediately for alarm features that mandate urgent evaluation: unintentional weight loss, rectal bleeding, iron deficiency anemia, acute-onset constipation in older adults (>50 years), and rectal prolapse. 1, 2 Patients with any of these features require prompt subspecialist referral and cannot be managed with empiric therapy alone. 2

Key History Elements

• Medication review is the single most critical first step—opioids, anticholinergics, calcium channel blockers, and psychotropics are the most common culprits and should be discontinued or substituted when possible. 3, 4
• Document stool frequency, consistency (using Bristol Stool Scale), straining severity, sensation of incomplete evacuation, need for digital maneuvers, and sensation of anorectal blockage. 5
• Ask specifically about alternating diarrhea/constipation (suggests IBS-C rather than functional constipation), nausea/vomiting (also suggests IBS-C), and abdominal pain relieved by defecation (IBS-C). 6
• Identify secondary causes: hypothyroidism, hypercalcemia, hypokalemia, diabetes, neurologic disorders (Parkinson's, spinal cord lesions). 3, 2

Physical Examination

• Digital rectal examination (DRE) is mandatory before initiating any oral laxative therapy—it identifies fecal impaction (which requires manual disimpaction first), assesses sphincter tone, detects masses, and evaluates for rectocele or prolapse. 5, 4, 7
• Perform abdominal examination with auscultation to assess for distension, masses, and bowel sounds. 5
• Inspect the perineum for fissures, hemorrhoids, skin tags, and prolapse. 5

---

Diagnostic Workup

Investigations are not routinely necessary—chronic constipation is a clinical diagnosis. 7 However, selective testing is warranted in specific scenarios:

When to Order Laboratory Tests

• Check corrected calcium, TSH, and potassium only when clinically suspected based on history (e.g., fatigue, polyuria, muscle weakness). 5, 3
• These metabolic causes are uncommon but easily reversible. 3

When to Order Imaging

• Plain abdominal X-ray has poor sensitivity (74-84%) and specificity (50-72%) for obstruction and should not be used routinely. 7
• CT abdomen/pelvis is indicated only for suspected obstruction, severe symptoms with unclear etiology, or concern for structural lesions (sensitivity 93-96%, specificity 93-100%). 7
• Do not delay empiric treatment while awaiting imaging in uncomplicated cases. 7

When to Refer for Specialized Testing

Refer for anorectal manometry, balloon expulsion test, defecography, or colonic transit studies only if:

• Patient fails 8-12 weeks of optimized medical therapy (fiber, PEG, stimulant laxatives). 1
• History strongly suggests outlet dysfunction: need for digital maneuvers to evacuate, sensation of obstruction, or evidence of large rectocele on DRE. 8, 6
• Considering surgical intervention. 1

Note: Symptoms alone cannot reliably distinguish slow-transit from outlet constipation—straining occurs in 82-94% of all subtypes, and "incomplete evacuation" has only 54% specificity for outlet dysfunction. 8 Therefore, empiric treatment should precede specialized testing in most cases.

---

Stepwise Management Algorithm

Step 1: Non-Pharmacological Measures (All Patients)

• Ensure easy toilet access, especially for elderly or mobility-impaired patients—this single environmental modification significantly reduces recurrence. 3, 4
• Educate patients to attempt defecation twice daily, 30 minutes after meals (when gastrocolic reflex is strongest), and limit straining to ≤5 minutes. 3, 4
• Increase fluid intake to ≥1.5 liters daily. 3, 4
• Encourage any tolerated physical activity, even bed-to-chair transfers in frail patients. 3, 4
• Provide dietetic support for patients with decreased oral intake from anorexia or chewing difficulties. 4

Step 2: First-Line Pharmacological Therapy

Initiate polyethylene glycol (PEG) 17 grams once daily as the preferred first-line laxative. 5, 3, 4 The AGA/ACG 2023 guideline gives PEG a strong recommendation with moderate-quality evidence based on durable efficacy over 6 months and excellent safety even in elderly patients with cardiac or renal failure. 5

• PEG is superior to fiber supplements (psyllium) for most patients—fiber has only conditional recommendation with very low-quality evidence and causes significant flatulence. 5
• Fiber supplements should be reserved for patients with mild constipation and low baseline dietary fiber intake. 5
• Never prescribe bulk-forming laxatives (psyllium, methylcellulose) to non-ambulatory patients or those with low fluid intake—they markedly increase mechanical obstruction risk. 4

Dose Escalation Protocol

• If no bowel movement within 3-4 days on PEG 17g daily, increase to 34g daily (17g twice daily). 4
• If still ineffective after another 3-4 days, add oral bisacodyl 10-15mg daily. 4

Step 3: Alternative or Adjunctive Agents

If PEG is not tolerated or ineffective:

Osmotic Laxatives:

• Magnesium oxide (conditional recommendation, very low evidence)—start low dose and titrate; absolutely contraindicated in any degree of renal impairment due to hypermagnesemia risk. 5, 4
• Lactulose 30-60mL twice to four times daily (conditional recommendation, very low evidence)—reserve for PEG failures due to dose-dependent bloating and flatulence. 5, 4

Stimulant Laxatives:

• Bisacodyl or sodium picosulfate (strong recommendation, moderate evidence)—excellent for short-term use (≤4 weeks) or rescue therapy. 5 Long-term daily use is probably safe but data are limited. 5
• Senna (conditional recommendation, very low evidence)—similar efficacy to bisacodyl but less studied. 5

Step 4: Prescription Secretagogues and Prokinetics

For patients who fail over-the-counter therapies after 8-12 weeks, consider prescription agents:

• Linaclotide 145-290 mcg daily (strong recommendation, moderate evidence). 5
• Plecanatide 3mg daily (strong recommendation, moderate evidence). 5
• Prucalopride 2mg daily (strong recommendation, moderate evidence). 5
• Lubiprostone 24 mcg twice daily (conditional recommendation, very low evidence). 5

These agents are significantly more expensive than OTC options and should be reserved for refractory cases. 5

---

Special Populations and Situations

Elderly Patients

• PEG 17g daily remains the safest first-line choice—it does not cause electrolyte disturbances even in cardiac or renal failure. 3, 4
• Avoid magnesium-containing laxatives entirely in elderly patients due to high prevalence of occult renal impairment. 3, 4
• Avoid liquid paraffin in bed-bound or dysphagic patients due to aspiration lipoid pneumonia risk. 4
• For patients with dysphagia or recurrent impaction, prioritize rectal therapies (suppositories or enemas) over oral agents. 4
• Use isotonic saline enemas (500-1000mL) rather than sodium phosphate enemas—they cause fewer electrolyte disturbances. 4

Fecal Impaction

• When DRE confirms impaction, perform manual disimpaction (digital fragmentation and extraction) after pre-medication with analgesia ± anxiolysis—this is first-line therapy and should achieve complete clearance in a single session. 3, 4
• Follow immediately with PEG 17g daily plus bisacodyl suppository (one rectally daily to twice daily) to prevent re-impaction. 4
• Disimpaction should only be repeated if re-impaction occurs despite maintenance therapy, not on a scheduled basis. 4

Opioid-Induced Constipation

• All patients starting opioids should receive prophylactic laxatives at opioid initiation unless they have pre-existing diarrhea. 4
• Osmotic (PEG) or stimulant laxatives (senna, bisacodyl) are preferred agents. 4
• Do not use bulk-forming laxatives for opioid-induced constipation. 4
• Peripherally acting mu-opioid receptor antagonists (PAMORAs) can be considered for refractory cases but are costly. 4

---

Critical Contraindications and Pitfalls

Absolute Contraindications to Enemas

Never administer enemas in patients with: neutropenia, thrombocytopenia, paralytic ileus, intestinal obstruction, recent colorectal or gynecologic surgery, recent anal/rectal trauma, severe colitis, toxic megacolon, undiagnosed abdominal pain, or recent pelvic radiotherapy. 4

Medication-Specific Warnings

• Magnesium-based laxatives (magnesium hydroxide, magnesium citrate) are absolutely contraindicated in any degree of renal impairment. 3, 4
• Monitor elderly patients on diuretics or cardiac glycosides closely for dehydration and electrolyte disturbances when using laxatives. 4
• Adequate hydration must be encouraged with fiber supplementation to prevent obstruction. 5

Common Errors to Avoid

• Do not start oral laxatives before performing DRE—you may miss impaction requiring manual disimpaction. 4, 7
• Do not prescribe fiber to non-ambulatory patients with limited fluid intake. 4
• Do not delay medication review—constipating medications are the most reversible cause. 3, 4
• Do not order routine imaging—constipation is a clinical diagnosis and treatment should not be delayed for X-rays. 7